Parecoxib In Post Surgery (Hemicolectomy) Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-09-30

Study Completion Date

2005-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a phase III, multicenter, open label, pilot to evaluate the analgesic efficacy and safety of parecoxib 40 mg IV in the treatment of the pain following hemicolectomy in an optimal management of the surgical patient

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery

NCT00651300

Pain

TERMINATED PHASE3

Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy

NCT02204878

Hepatic Hemangioma Located in the Right Liver Laparotomy Surgery

UNKNOWN PHASE4

The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection

NCT02408146

Pain, Postoperative

UNKNOWN NA

Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy

NCT00346268

Pain, Postoperative

TERMINATED PHASE4

Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty

NCT02272660

Pain, Postoperative

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study was terminated prematurely due to recruitment issues on 31 January 2006. Safety concerns did not lead to the decision to terminate this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paracoxib

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients hospitalised for resection of left/right colon;
* preoperative health graded as ASA \<3.

Exclusion Criteria

* patients with any type of metastatic cancer, particularly metastatic colon cancer;
* patients with familial adenomatous polyps (sporadic adenomatous polyps are accepted);

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No